116 related articles for article (PubMed ID: 19509553)
1. Prognostic importance of vascular endothelial growth factor-A expression and vascular endothelial growth factor polymorphisms in epithelial ovarian cancer.
Smerdel MP; Waldstrøm M; Brandslund I; Steffensen KD; Andersen RF; Jakobsen A
Int J Gynecol Cancer; 2009 May; 19(4):578-84. PubMed ID: 19509553
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor gene polymorphisms in ovarian cancer.
Polterauer S; Grimm C; Mustea A; Concin N; Tanner B; Thiel F; Heinze G; Reinthaller A; Zeillinger R; Hefler LA
Gynecol Oncol; 2007 May; 105(2):385-9. PubMed ID: 17289129
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer.
Hefler LA; Mustea A; Könsgen D; Concin N; Tanner B; Strick R; Heinze G; Grimm C; Schuster E; Tempfer C; Reinthaller A; Zeillinger R
Clin Cancer Res; 2007 Feb; 13(3):898-901. PubMed ID: 17289883
[TBL] [Abstract][Full Text] [Related]
4. Vascular Endothelial Growth Factor (VEGF) Polymorphisms and Serum VEGF Levels in Women With Epithelial Ovarian Cancer, Benign Tumors, and Healthy Ovaries.
González-Palomares B; Coronado Martín PJ; Maestro de Las Casas ML; Veganzones de Castro S; Rafael Fernández S; Vidaurreta Lázaro M; De la Orden García V; Vidart Aragon JA
Int J Gynecol Cancer; 2017 Jul; 27(6):1088-1095. PubMed ID: 28574932
[TBL] [Abstract][Full Text] [Related]
5. Expression of the angopoietin-1, angopoietin-2, Tie2, and vascular endothelial growth factor gene in epithelial ovarian cancer.
Hata K; Nakayama K; Fujiwaki R; Katabuchi H; Okamura H; Miyazaki K
Gynecol Oncol; 2004 Apr; 93(1):215-22. PubMed ID: 15047239
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor polymorphisms (-460C/T, +405G/C, and 936C/T) and endometriosis: their influence on vascular endothelial growth factor expression.
Cosín R; Gilabert-Estellés J; Ramón LA; España F; Gilabert J; Romeu A; Estellés A
Fertil Steril; 2009 Oct; 92(4):1214-1220. PubMed ID: 18930211
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor polymorphisms and a synchronized examination of plasma and tissue expression in epithelial ovarian cancers.
Bhaskari J; Premalata CS; Shilpa V; Rahul B; Pallavi VR; Ramesh G; Krishnamoorthy L
Tumour Biol; 2016 Jan; 37(1):1017-23. PubMed ID: 26264619
[TBL] [Abstract][Full Text] [Related]
8. Expression of the vascular endothelial growth factor (VEGF) gene in epithelial ovarian cancer: an approach to anti-VEGF therapy.
Hata K; Watanabe Y; Nakai H; Hata T; Hoshiai H
Anticancer Res; 2011 Feb; 31(2):731-7. PubMed ID: 21378364
[TBL] [Abstract][Full Text] [Related]
9. Association of vascular endothelial growth factor single nucleotide polymorphisms on the prognosis of breast cancer patients.
Rani J; Rahul B; Ramesh G; Krishnamoorthy L; Shilpa C; Ramaswamy G; Deshmane V
Indian J Cancer; 2014; 51(4):512-7. PubMed ID: 26842181
[TBL] [Abstract][Full Text] [Related]
10. Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms--a case-control study in an Omani population.
Al-Moundhri MS; Al-Nabhani M; Burney IA; Al-Farsi AA; Al-Bahrani B
Mol Carcinog; 2009 Dec; 48(12):1170-6. PubMed ID: 19676106
[TBL] [Abstract][Full Text] [Related]
11. Expression of hypoxia-inducible factor 1alpha gene affects the outcome in patients with ovarian cancer.
Shimogai R; Kigawa J; Itamochi H; Iba T; Kanamori Y; Oishi T; Shimada M; Sato S; Kawaguchi W; Sato S; Terakawa N
Int J Gynecol Cancer; 2008; 18(3):499-505. PubMed ID: 18476949
[TBL] [Abstract][Full Text] [Related]
12. Combined effect of vascular endothelial growth factor and its receptor polymorphisms in endometriosis: a case-control study.
Cardoso JV; Abrão MS; Vianna-Jorge R; Ferrari R; Berardo PT; Machado DE; Perini JA
Eur J Obstet Gynecol Reprod Biol; 2017 Feb; 209():25-33. PubMed ID: 27836223
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 gene polymorphisms in patients with gastrointestinal stromal tumors.
Kang BW; Kim JG; Chae YS; Bae HI; Kwon O; Chung HY; Yu W; Song HS; Kang YN; Ryu SW; Lee KH; Bae YK; Choi JH; Kim SW; Ryoo HM; Cho CH; Chae HD; Park KW; Gu MJ; Bae BJ
Asia Pac J Clin Oncol; 2014 Jun; 10(2):e40-5. PubMed ID: 23551429
[TBL] [Abstract][Full Text] [Related]
14. Association of vascular endothelial growth factor (VEGF) gene polymorphism and increased serum VEGF concentration with pancreatic adenocarcinoma.
Sivaprasad S; Govardhan B; Harithakrishna R; Venkat Rao G; Pradeep R; Kunal B; Ramakrishna N; Anuradha S; Reddy DN
Pancreatology; 2013; 13(3):267-72. PubMed ID: 23719599
[TBL] [Abstract][Full Text] [Related]
15. Expression of semaphorins, vascular endothelial growth factor, and their common receptor neuropilins and alleic loss of semaphorin locus in epithelial ovarian neoplasms: increased ratio of vascular endothelial growth factor to semaphorin is a poor prognostic factor in ovarian carcinomas.
Osada R; Horiuchi A; Kikuchi N; Ohira S; Ota M; Katsuyama Y; Konishi I
Hum Pathol; 2006 Nov; 37(11):1414-25. PubMed ID: 17010410
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between -460 C/T and 936 C/T of the vascular endothelial growth factor and angiopoietin-2 exon 4 G/A polymorphisms and ovarian, cervical, and endometrial cancers.
Konac E; Onen HI; Metindir J; Alp E; Biri AA; Ekmekci A
DNA Cell Biol; 2007 Jul; 26(7):453-63. PubMed ID: 17630849
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma.
Shen GH; Ghazizadeh M; Kawanami O; Shimizu H; Jin E; Araki T; Sugisaki Y
Br J Cancer; 2000 Jul; 83(2):196-203. PubMed ID: 10901370
[TBL] [Abstract][Full Text] [Related]
18. The relationship of VEGF polymorphisms with serum VEGF levels and progression-free survival in patients with epithelial ovarian cancer.
Steffensen KD; Waldstrøm M; Brandslund I; Jakobsen A
Gynecol Oncol; 2010 Apr; 117(1):109-16. PubMed ID: 20056267
[TBL] [Abstract][Full Text] [Related]
19. A vascular endothelial growth factor gene polymorphism predicts malignant potential in intraductal papillary mucinous neoplasm.
Yabusaki N; Yamada S; Shimoyama Y; Fujii T; Kanda M; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Nakao A; Kodera Y
Pancreas; 2015 May; 44(4):608-14. PubMed ID: 25875799
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma.
Nishida N; Yano H; Komai K; Nishida T; Kamura T; Kojiro M
Cancer; 2004 Sep; 101(6):1364-74. PubMed ID: 15368324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
